Table 3.
Conditions | Daily Opioid Use (OME, mg) | N | Country or region |
References |
---|---|---|---|---|
Sickle cell disease
(SCD) |
Median (IQR): 6.1 (1.7-26.3) | 203 | US | This study |
Chronic non-cancer
pain (CNCP) |
Mean (SD): 58 (79) | 11,989 | Germany | (24) |
Median (IQR): 75 (36-145) | 1417 | Australia | (19) | |
Median (IQR): 180 (60-501) | 145 | Canada | (22) | |
Median (Range): 20.3 (5-72.1) | 60 | US | (21) | |
Mean (SD): 118 (149) | 466 | US | (23) | |
Cancer pain | Median: 45 | 91 | US | (25) |
Median (IQR): 120 (45-270) | 198 | US | (26) | |
Mean (SD): 167 (170) | 123 | Egypt | (28) | |
Median (Range): 30 (20-60) | 371 | Portugal | (29) |
A systematic literature search on all articles published from January 2012 to October 2015 was performed in November 2015 using Pubmed. The keyword “morphine equivalent” was used.
The result was derived from the total consumption of opioids.